STAT1 and cancer: Future studies should explore the effect of cardiac glycosides on these families of STAT1 regulators to gain more understanding into the potential of cardiac glycosides to regulate immune cell function through their primary target ATP1A1, downstream effector STAT1, and immune checkpoint proteins in cancer cells.